The guide to injecting tirzepatide in the stomach covers the most popular injection site, though other injection sites work equally well
For those with multiple chronic conditions, complex medication regimens, or clinical situations that warrant a more comprehensive workup before initiating GLP-1 therapy, a traditional relationship with an obesity medicine specialist or endocrinologist may provide a better level of oversight
doi:10.1111/j.1468-3083.2011.04062.x Contribution statement DJD and CFR reviewed the literature, drafted and wrote the manuscript and approved the final version without any outside assistance Duality of interest D.J
MMP-13 (matrix metalloproteinase-13) is involved in cartilage degradation;331 ADAMTS5 is closely related to cartilage damage and inflammation.332,333,334 The NO produced by iNOS, as a free radical, can regulate intracellular signal transduction and modulate the inflammatory response.335,336 The expression of iNOS is primarily activated by the NF-B pathway, which is activated and translocated to the nucleus upon inflammatory stimulation (such as bacterial endotoxins or pro-inflammatory cytokines), thus increasing the transcription and expression of iNOS.337,338,339 GLP-1 can exert its anti-inflammatory effects by activating its receptor, GLP-1R.339 When GLP-1 binds to GLP-1R, it activates the cAMP signaling pathway, leading to increased cAMP levels.1,340 The rise in cAMP further activates PKA, which can inhibit the NF-B signaling pathway, reducing the production of inflammatory factors such as iNOS and other inflammation-related proteins.12,340,341 The expression of MMP-13 is regulated by IL-1 and TNF-
